Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.

23/11/2023
/ Publications

To examine the superiority of PBT to photon-based RT in treating esophageal cancer patients, this systematic review included 23 original studies (1 randomized...

Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.

23/11/2023
/ Publications

A review article by the group from National Cancer Center, Korea detailed the dosimetric and clinical benefits of PBT in the settings of early, intermediate and...

Clinical and Dosimetric Results of Proton or Photon Radiotherapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.

23/11/2023
/ Publications

Published in the Red Journal, this study from Taiwan retrospectively analyzed the outcomes of 159 patients with >5 cm non-metastatic HCC who underwent...

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.

23/11/2023
/ Publications

This study from Japan was set to compare the survival outcomes of PBT with those of radiofrequency ablation (RFA) in patients with treatment-naïve solitary HCC...

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.

23/11/2023
/ Publications

Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...

Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center.

23/11/2023
/ Publications

Published in the Green Journal, this study by MD Anderson group reported clinical outcomes of 2772 patients with localized prostate cancer treated with proton...

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

23/11/2023
/ Publications

This retrospective study by the group from Proton Therapy Center, Czech, analyzed clinical outcomes of 853 patients with prostate cancer treated with an ultra...

Ensuring continued success at one of the busiest Proton Centers in the world

17/05/2021
/ Webinar
/
PT101

View our Breakfast Briefing Webinar from the virtual NAPT 2021 conference with Jim Metz’ from UPENN presenting on Ensuring continued success at one of the...

Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas.

23/11/2023
/ Publications

This randomized phase 2 trial by multiple groups from France reported that 8 x 6.5 Gy scheme is feasible without deteriorating local control and with similar...

Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan.

23/11/2023
/ Publications

This study from Japan estimated the incremental cost-effectiveness ratio (ICER) of PBT as a replacement for three-dimensional conformal RT (3DCRT). The...